Switch View
© BusinessWire
21.08.2025
ISIN: US4131971040
Harmony Biosciences Holdings Inc
HRMY
LISTED
NASDAQ
Harmony Biosciences to Participate in 2025 Cantor Global Healthcare Conference
News Preview
Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), today announced that Harmony's management team will participate in a fireside chat at the 2025 Cantor Global Healthcare Conference in New York, N.Y., on Thursday, September 4, 2025, at 2:10 p.m. ET.
A webcast of the fireside chat will be available on the investor page of the Harmony Biosciences...
Themefolio
Profiler
Peergroup
© PR Newswire
21.08.2025
ISIN: US4330001060
Hims & Hers Health Inc
HIMS
LISTED
NYSE
INVESTOR DEADLINE MONDAY: Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - HIMS
News Preview
SAN DIEGO, Aug. 21, 2025 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Hims & Hers Health, Inc. (NYSE: HIMS) securities between April 29, 2025 and June 23, 2025, all dates inclusive (the "Class Period"), have until this Monday, August 25, 2025 to seek appointment as lead plaintiff of the Hims &...
Themefolio
Profiler
Peergroup
© BusinessWire
21.08.2025
ISIN: US36266G1076
GE Healthcare Technologies Inc
GEHC
LISTED
NASDAQ
GE HealthCare management to present at upcoming investor conferences
News Preview
GE HealthCare (Nasdaq: GEHC) is announcing that members of its management team will present at the following upcoming investor conferences.
2025 Wells Fargo Healthcare Conference – Thursday, September 4, 2025 at 8:45 am ET/7:45 am CT
Morgan Stanley 23rd Annual Global Healthcare Conference – Tuesday, September 9, 2025 at 9:15 am ET/8:15 am CT...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© BusinessWire
21.08.2025
ISIN: US1407553072
Tvardi Therapeutics Inc
TVRD
LISTED
NASDAQ
Tvardi Therapeutics to Participate in the Cantor Global Healthcare Conference
News Preview
Tvardi Therapeutics, Inc. (“Tvardi”) (NASDAQ: TVRD), a clinical-stage biopharmaceutical company focused on the development of novel, oral, small molecule therapies targeting STAT3 to treat fibrosis-driven diseases, today announced that the Company’s Management will participate in a fireside chat at the Cantor Global Healthcare Conference on Thursd...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© Newsfile
21.08.2025
ISIN: CA58471K2020
Medicus Pharma Ltd.
MDCX
LISTED
TSX
Medicus Pharma Ltd. Provides Update on Doxorubicin Containing Novel Microneedle Array (D-MNA) Clinical Development Program for the Treatment of Basal Cell Carcinoma (BCC) of the Skin and Reports Second Quarter 2025 Financial Highlights
News Preview
US Food and Drug Administration (FDA) has accepted the company's Type C meeting request and SKNJCT-003 Phase 2 study has randomized more than 75% of patientsPhiladelphia, Pennsylvania--(Newsfile Corp. - August 21, 2025) - Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company"), a biotech/life sciences company focused on advancing the clinic...
Themefolio
Profiler
Peergroup
© Newsfile
21.08.2025
ISIN: CA64082X2032
Nervgen Pharma Corp.
NGEN
LISTED
TSX
NervGen Pharma's NVG-291-R Demonstrates Significant Functional Recovery in Department of Defense-Sponsored Preclinical Models of Traumatic Hearing Loss and Peripheral Nerve Injury
News Preview
Demonstrated significant hearing restoration in blast-induced sensorineural hearing loss modelsPromoted significant functional recovery and axonal regeneration in peripheral nerve injury modelsReinforced NVG-291's broad therapeutic potential with new data across three distinct injury modelsVancouver, British Columbia--(Newsfile Corp. - August 21, 2...
Themefolio
Profiler
Peergroup
© PR Newswire
21.08.2025
ISIN: US9224751084
Veeva Systems Inc
VEEV
LISTED
NYSE
Leaders Come Together to Advance the Industry at Veeva Summit
News Preview
Alnylam Pharmaceuticals, BeOne Medicines, Intercept Pharmaceuticals, Merck, Pfizer, and Sanofi among biopharmas sharing strategies that set future direction
Veeva to showcase innovations, including deep industry-specific Veeva AI in Vault Platform and Veeva applications
PLEASANTON, Calif., Aug. 21, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV)...
Themefolio
Profiler
Peergroup
© BusinessWire
21.08.2025
ISIN: GG00BMF1JR16
Genius Sports Limited
GENI
LISTED
NYSE
Genius Sports Announces Upcoming Conference Schedule
News Preview
Genius Sports Limited (NYSE:GENI) (“Genius Sports”), the official data, technology and broadcast partner that powers the global ecosystem connecting sports, betting and media, will participate in six upcoming investor conferences.
Benchmark’s Tech, Media & Telecom Conference on September 3, 2025
BofA Securities’ Gaming and Lodging Confer...
Themefolio
Profiler
Peergroup
© BusinessWire
21.08.2025
ISIN: US8036071004
Sarepta Therapeutics Inc
SRPT
LISTED
NASDAQ
Sarepta Therapeutics Announces Refinancing of Approximately $700 Million of 1.25% Convertible Senior Notes due 2027
News Preview
Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that it has entered into separate, privately negotiated exchange agreements with a limited number of holders of its 1.25% convertible senior notes due 2027 (the “Existing Convertible Notes”) in each case pursuant to exemptions from...
Themefolio
Profiler
Peergroup
© BusinessWire
21.08.2025
ISIN: US29251M1062
Enanta Pharmaceuticals Inc
ENTA
LISTED
NASDAQ
Enanta Pharmaceuticals to Participate in September Investor Conferences
News Preview
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and immunological diseases, today announced that members of management will participate in three investor conferences in September:
Cantor Global Healthcare Conference 2025: Fireside Chat on Wednesda...
Themefolio
Profiler
Peergroup
© BusinessWire
21.08.2025
ISIN: US71944F1066
Phreesia, Inc.
PHR
LISTED
NYSE
Phreesia and Sesame Workshop Announce 5-Year Collaboration to Improve the Health of Millions of Children Through the Power of Sesame Street
News Preview
Phreesia, a leader in patient intake, outreach and activation that enables one in seven patient visits across the U.S., and Sesame Workshop, the global nonprofit behind Sesame Street, are pleased to announce a collaboration to educate and engage parents and caregivers of young children at the point of care.
This press release features multimedia....
Themefolio
Profiler
Peergroup
© PR Newswire
21.08.2025
ISIN: US4330001060
Hims & Hers Health Inc
HIMS
LISTED
NYSE
HIMS Investors Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit with the Schall Law Firm
News Preview
LOS ANGELES, Aug. 21, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Hims & Hers Health, Inc. ("Hims & Hers" or "the Company") (NYSE: HIMS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated ther...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© PR Newswire
21.08.2025
ISIN: US9553061055
West Pharmaceutical Services Inc
WST
LISTED
NYSE
West to Participate in Upcoming Investor Conferences in September 2025
News Preview
EXTON, Pa., Aug. 21, 2025 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will present at multiple investor conferences in September. Here are the details of the presentations:...
Themefolio
Profiler
Peergroup
© Newsfile
21.08.2025
ISIN: CA41138T1057
Happy Belly Food Group Inc.
HBFG
LISTED
CSE
Happy Belly Food Group Closes Acquisition of SALUS Fresh Foods QSR Restaurant Chain
News Preview
Toronto, Ontario--(Newsfile Corp. - August 21, 2025) - Happy Belly Food Group Inc. (CSE: HBFG) (OTCQB: HBFGF) ("Happy Belly" or the "Company"), a leader in acquiring and scaling emerging food brands across Canada is pleased to announce that further to its news release on November 1st, 2024 announcing the signing of a definitive agreement to acquire...
Themefolio
Profiler
Peergroup
© BusinessWire
21.08.2025
ISIN: US07725L1026
BeOne Medicines Ltd.
ONC
LISTED
NASDAQ
European Commission Approves Tablet Formulation of BeOne Medicines’ BRUKINSA® for All Approved Indications
News Preview
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the European Commission has approved a new film-coated tablet formulation of BRUKINSA® (zanubrutinib) for all approved indications.
"Developed to meet the real-world needs of patients, the new BRUKINSA tablet formulation aims to simplify...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
21.08.2025
ISIN: US47010C4096
Jaguar Health, Inc.
JAGX
LISTED
NASDAQ
Jaguar Health Participating in August 25-26 Animal Health Summit with Goal of Securing Collaboration to Expand Canalevia's Indication to Treatment of General Diarrhea in Dogs
News Preview
Canalevia® (crofelemer delayed-release tablets), under the name Canalevia®-CA1, is conditionally approved by the FDA for treatment of CID in dogsCompany strategy: In discussions with multiple potential animal health company partners to expand the indication and commercialize Canalevia for treatment of general diarrhea globallyDiarrhea is...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
21.08.2025
ISIN: CA0717341071
Bausch Health Companies Inc
BHC
LISTED
TSX
Bausch Health, Canada Inc. Treatment for Acne Vulgaris, (Pr)CABTREO(TM) (Clindamycin Phosphate, Adapalene and Benzoyl Peroxide Gel), Now Available Through Public Drug Plans of Quebec and Saskatchewan
News Preview
LAVAL, QC / ACCESS Newswire / August 21, 2025 / Bausch Health, Canada Inc., part of Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), a global, diversified pharmaceutical company, today announced that PrCABTREO™ (clindamycin phosphate, adapalene and benzoyl peroxide) gel 1.2% w/w, 0.15% w/w and 3.1% w/w, for the treatment of acne vulgaris,1 i...
Themefolio
Profiler
Peergroup
© EQS Newswire
21.08.2025
ISIN: CH1262055788
EvoNext Holding Ltd
EVE
LISTED
SIX
EvoNext Holdings SA publishes half-year report 2025
News Preview
PRESS RELEASE | AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR
EvoNext Holdings SA publishes half-year report 2025
Reinach, Switzerland, 21 August 2025 — EvoNext Holdings SA, renamed from Evolva Holding SA following shareholder approval at the Extraordinary Shareholder Meeting of 25 July 2025, (SIX: EVE) (“EvoNext”) today published the half-year re......
Themefolio
Profiler
Peergroup
© ACCESSWIRE
21.08.2025
ISIN: US60770K1079
Moderna, Inc
MRNA
LISTED
NASDAQ
Moderna to Present at Upcoming Conferences in September 2025
News Preview
CAMBRIDGE, MA / ACCESS Newswire / August 21, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced its participation in the following upcoming investor conferences:Morgan Stanley's 23rd Annual Global Healthcare Conference, on Monday, September 8th at 10:00am ETBernstein Insights: Healthcare Leaders and Disruptors, on Thursday, September 25th at 10:30a...
Themefolio
Profiler
Peergroup
© EQS Newswire
21.08.2025
ISIN: CH1429326825
Siegfried Holding AG
SFZN
LISTED
SIX
Siegfried on track to deliver profitable growth
News Preview
Media Release
Zofingen, August 21, 2025
Ad hoc announcement pursuant to Art. 53 Listing Rules
In the first half of 2025, Siegfried (SIX: SFZN) successfully executed its strategy and continued to grow profitably. As expected, the seasonality between the half years is stronger in 2025 compared to previous years. Performance was supported by strong ......
Themefolio
Profiler
Peergroup
© Globe Newswire
21.08.2025
ISIN: SE0006219176
Arcoma AB
ARCOMA
LISTED
STO
Kvartalsrapport Q2 2025 – Stark efterfrågan i Europa, USA påverkat av politiska faktorer. (MAR)
News Preview
PRESSRELEASE...
Themefolio
Profiler
Peergroup
© Globe Newswire
21.08.2025
ISIN: DK0060027142
ALK-Abelló A/S
ALK B
LISTED
CPH
Six-month interim report (Q2) 2025 (unaudited)
News Preview
ALK delivers 12% organic revenue growth with operating profit up 41% in Q2...
Themefolio
Profiler
Peergroup
© Globe Newswire
21.08.2025
ISIN: FI4000087861
Herantis Pharma Oyj
HRTIS
LISTED
HEL
Herantis Pharma releases 1H 2025 report today
News Preview
Espoo, Finland, 21 August 2025: Herantis Pharma Plc ("Herantis"), a clinical-stage company developing disease-modifying therapies to stop Parkinson’s disease, releases today the Company’s 1H 2025 report. The full report is available at the Company’s website: www.herantis.com....
Themefolio
Profiler
Peergroup
© Globe Newswire
21.08.2025
ISIN: US00534A1025
Invivyd Inc
IVVD
LISTED
NASDAQ
Invivyd Announces Pricing of $50 Million Public Offering of Common Stock and Pre-Funded Warrants
News Preview
Invivyd Announces Pricing of $50 Million Public Offering of Common Stock and Pre-Funded Warrants...
Themefolio
Profiler
Peergroup
© BusinessWire
21.08.2025
ISIN: US60783X1046
ModivCare, Inc.
MODVQ
LISTED
OTC
Modivcare Enters into Comprehensive Restructuring Agreement to Strengthen its Future, Reduce Debt and Inject Capital
News Preview
Modivcare Inc. (the “Company” or “Modivcare”) (Nasdaq: MODV), a technology-enabled healthcare services company providing a platform of integrated supportive care solutions focused on improving health outcomes, today announced that it has taken necessary and decisive action intended to strengthen its financial foundation while continuing to provide...
Themefolio
Profiler
Peergroup
© Globe Newswire
21.08.2025
ISIN: AU000000TLX2
Telix Pharmaceuticals Ltd
TLX
LISTED
ASX
Telix 2025 Half-Year Results: Strong commercial performance enables investment for long-term growth
News Preview
MELBOURNE, Australia and INDIANAPOLIS, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces its financial results for the half-year ended 30 June 2025. All figures are in USD unless stated otherwise....
Themefolio
Profiler
Peergroup
© Globe Newswire
20.08.2025
ISIN: KYG0519B1023
Ascentage Pharma Group International
6855
LISTED
HKSE
Ascentage Pharma Reports 2025 Interim Unaudited Six Months Financial Results and Business Updates
News Preview
ROCKVILLE, Md. and SUZHOU, China, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (Ascentage Pharma) (NASDAQ: AAPG; HKEX: 6855) (referred hereinto as “Ascentage Pharma,” the “Company,” “we,” “us” or “our”), a global, commercial stage, integrated biopharmaceutical company engaged in the discovery, development and commerciali...
Themefolio
Profiler
Peergroup
© PR Newswire
20.08.2025
ISIN: US15135B1017
Centene Corp
CNC
LISTED
NYSE
CENTENE CORPORATION RECOMMENDS STOCKHOLDERS REJECT "MINI-TENDER" OFFER FROM TRC CAPITAL INVESTMENT CORPORATION
News Preview
ST. LOUIS, Aug. 20, 2025 /PRNewswire/ -- Centene Corporation (NYSE: CNC) (Centene) announced today that it received notice of an unsolicited "mini-tender" offer from TRC Capital Investment Corporation (TRC) dated August 5th, 2025. Centene is in no way affiliated with TRC. TRC has offered to purchase up to 4 million shares of Centene's common sto...
Themefolio
Profiler
Peergroup
© BusinessWire
20.08.2025
ISIN: US05380C1027
AVITA Medical Inc
RCEL
LISTED
NASDAQ
Securities Fraud Investigation Into AVITA Medical, Inc. (RCEL) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
News Preview
The Law Offices of Frank R. Cruz announces an investigation of AVITA Medical, Inc. (“Avita” or the “Company”) (NASDAQ: RCEL) on behalf of investors concerning the Company’s possible violations of federal securities laws.
IF YOU ARE AN INVESTOR WHO LOST MONEY ON AVITA MEDICAL, INC. (RCEL), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM...
Themefolio
Profiler
Peergroup
© PR Newswire
20.08.2025
ISIN: VGG111961055
Biohaven Ltd.
BHVN
LISTED
NYSE
Biohaven Ltd. Stockholders are Urged to Seek Representation to Lead the BHVN Class Action: Contact Robbins LLP for More Information
News Preview
SAN DIEGO, Aug. 20, 2025 /PRNewswire/ -- Robbins LLP reminds stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired Biohaven Ltd. (NYSE: BHVN) securities between March 24, 2023 and May 14, 2025. Biohaven is a biopharmaceutical company that discovers, develops, and commercializes therapies for immunol...
Themefolio
Profiler
Peergroup
© PR Newswire
20.08.2025
ISIN: US02155H2004
Altimmune Inc
ALT
LISTED
NASDAQ
ALT STOCK: Robbins LLP Reminds ALT Stockholders of the Opportunity to Lead the Class Action Lawsuit Against Altimmune, Inc.
News Preview
SAN DIEGO, Aug. 20, 2025 /PRNewswire/ -- Robbins LLP reminds stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired Altimmune, Inc. (NASDAQ: ALT) securities between August 10, 2023 and June 25, 2025. Altimmune is a clinical stage biopharmaceutical company focused on developing treatments for obesity,...
Themefolio
Profiler
Peergroup
© PR Newswire
20.08.2025
ISIN: US78349D1072
Rxsight Inc
RXST
LISTED
NASDAQ
RXST Stockholders with Large Losses Should Contact Robbins LLP for Information About the RxSight, Inc. Class Action
News Preview
SAN DIEGO, Aug. 20, 2025 /PRNewswire/ -- Robbins LLP reminds stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired RxSight, Inc. (NASDAQ: RXST) securities between November 7, 2024 and July 8, 2025. RxSight is a commercial-stage medical technology company, engaged in the research and development, man...
Themefolio
Profiler
Peergroup
© BusinessWire
20.08.2025
ISIN: US8051111016
Savara Inc
SVRA
LISTED
NASDAQ
New England Journal of Medicine (NEJM) to Publish Results From Savara’s Pivotal Phase 3 IMPALA-2 Clinical Trial in Autoimmune Pulmonary Alveolar Proteinosis (Autoimmune PAP)
News Preview
Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, announced that the results from the Phase 3 IMPALA-2 clinical trial will be published online in NEJM. The manuscript, titled “A Phase 3 Trial of Inhaled Molgramostim Therapy in Autoimmune Pulmonary Alveolar Proteinosis” will a...
Themefolio
Profiler
Peergroup
© PR Newswire
20.08.2025
ISIN: KYG0405D1051
Angelalign Technology Inc
6699
LISTED
HKSE
Angelalign Technology Denies Patent Infringement and Vows Vigorous Defense
News Preview
SAN CLEMENTE, Calif., Aug. 21, 2025 /PRNewswire/ -- Angelalign Technology Inc. (6699.HK) ("Angel") categorically denies accusations of patent infringement by Align Technology Inc. (ALGN) and promises a vigorous defense.
"Angel has a rich heritage of clinically driven innovation during its 20-plus year history. Accusations by our competitor of pa...
Themefolio
Profiler
Peergroup
© PR Newswire
20.08.2025
ISIN: KYG0405D1051
Angelalign Technology Inc
6699
LISTED
HKSE
Angelalign Technology Denies Patent Infringement and Vows Vigorous Defense
News Preview
SAN CLEMENTE, Calif., Aug. 20, 2025 /PRNewswire/ -- Angelalign Technology Inc. (6699.HK) ("Angel") categorically denies accusations of patent infringement by Align Technology Inc. (ALGN) and promises a vigorous defense.
"Angel has a rich heritage of clinically driven innovation during its 20-plus year history. Accusations by our competitor of pa...
Themefolio
Profiler
Peergroup
© PR Newswire
20.08.2025
ISIN: US4330001060
Hims & Hers Health Inc
HIMS
LISTED
NYSE
Hims & Hers Health, Inc. (HIMS) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
News Preview
LOS ANGELES, Aug. 20, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Hims & Hers Health, Inc. ("Hims" or the "Company") (NYSE: HIMS) have opportunity to lead the securities fraud class action lawsuit....
Themefolio
Profiler
Peergroup
© PR Newswire
20.08.2025
ISIN: US15135B1017
Centene Corp
CNC
LISTED
NYSE
Centene Corporation (CNC) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
News Preview
BENSALEM, Pa., Aug. 20, 2025 /PRNewswire/ -- The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Centene Corporation ("Centene" or the "Company") (NYSE: CNC).
IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN CENTENE CORPORATION (CNC), CONTACT...
Themefolio
Profiler
Peergroup
© PR Newswire
20.08.2025
ISIN: US70975L1070
Penumbra Inc
PEN
LISTED
NYSE
Penumbra, Inc. to Present at Upcoming Investor Conferences
News Preview
ALAMEDA, Calif., Aug. 20, 2025 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the following investor conferences on the dates and times listed below.
Event:
2025 Wel...
Themefolio
Profiler
Peergroup
© BusinessWire
20.08.2025
ISIN: US6556631025
Nordson Corp
NDSN
LISTED
NASDAQ
Nordson Corporation Reports Third Quarter Fiscal 2025 Results and Updates Full Year Guidance
News Preview
Nordson Corporation (Nasdaq: NDSN) today reported results for the fiscal third quarter ended July 31, 2025. Sales were $742 million compared to the prior year’s third quarter sales of $662 million. The third quarter 2025 sales included a favorable acquisition impact of 8%, an organic sales increase of 2% and a favorable currency translation impact...
Themefolio
Profiler
Peergroup
© PR Newswire
20.08.2025
ISIN: KYG0405D1051
Angelalign Technology Inc
6699
LISTED
HKSE
Angelalign Technology Denies Patent Infringement and Vows Vigorous Defense
News Preview
SAN CLEMENTE, Calif., Aug. 20, 2025 /PRNewswire/ -- Angelalign Technology Inc. (6699.HK) ("Angel") categorically denies accusations of patent infringement by Align Technology Inc. (ALGN) and promises a vigorous defense.
"Angel has a rich heritage of clinically driven innovation during its 20-plus year history. Accusa...
Themefolio
Profiler
Peergroup
© PR Newswire
20.08.2025
ISIN: KYG0405D1051
Angelalign Technology Inc
6699
LISTED
HKSE
Angelalign Technology Denies Patent Infringement and Vows Vigorous Defense
News Preview
SAN CLEMENTE, Calif., Aug. 20, 2025 /CNW/ -- Angelalign Technology Inc. (6699.HK) ("Angel") categorically denies accusations of patent infringement by Align Technology Inc. (ALGN) and promises a vigorous defense.
"Angel has a rich heritage of clinically driven innovation during its 20-plus year history. Accusations b...
Themefolio
Profiler
Peergroup
© PR Newswire
20.08.2025
ISIN: IE00B4Q5ZN47
Jazz Pharmaceuticals PLC
JAZZ
LISTED
NASDAQ
Jazz Pharmaceuticals to Host Modeyso™ (dordaviprone) Investor Webcast on August 27, 2025
News Preview
DUBLIN, Aug. 20, 2025 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) will host an investor webcast on Wednesday, August 27, 2025, at 4:30 p.m. EDT / 9:30 p.m. IST to provide an overview of clinical data, patient need and commercialization strategy for Modeyso™ (dordaviprone). Modeyso was approved under accelerated approval by the U.S. Fo...
Themefolio
Profiler
Peergroup
© PR Newswire
20.08.2025
ISIN: IE00B4Q5ZN47
Jazz Pharmaceuticals PLC
JAZZ
LISTED
NASDAQ
Jazz Pharmaceuticals to Host Modeyso™ (dordaviprone) Investor Webcast on August 27, 2025
News Preview
DUBLIN, Aug. 20, 2025 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) will host an investor webcast on Wednesday, August 27, 2025, at 4:30 p.m. EDT / 9:30 p.m. IST to provide an overview of clinical data, patient need and commercialization strategy for Modeyso™ (dordaviprone). Modeyso was approved under accelerated approval by the U.S. Fo...
Themefolio
Profiler
Peergroup
© PR Newswire
20.08.2025
ISIN: US90240B1061
Tyra Biosciences Inc
TYRA
LISTED
NASDAQ
Tyra Biosciences Announces Participation at Upcoming Investor Events
News Preview
CARLSBAD, Calif., Aug. 20, 2025 /PRNewswire/ -- Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology, announced today that members of company management will participate in the foll...
Themefolio
Profiler
Peergroup
© BusinessWire
20.08.2025
ISIN: US3755581036
Gilead Sciences Inc
GILD
LISTED
NASDAQ
Gilead Sciences to Present at Upcoming Investor Conferences
News Preview
Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its executives will be speaking at the following investor conferences:
Cantor Global Healthcare Conference on Wednesday, September 3 at 11:30 AM Eastern Time
Wells Fargo Healthcare Conference on Thursday, September 4 at 11:00 AM Eastern Time
Morgan Stanley Annual Global Healthcar...
Themefolio
Profiler
Peergroup
© BusinessWire
20.08.2025
ISIN: US03969F1093
Arcus Biosciences Inc
RCUS
LISTED
NYSE
Arcus Biosciences to Participate in Three Upcoming Investor Conferences
News Preview
Arcus Biosciences (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for patients with cancer, announced that its management team will participate in the following upcoming investor conferences in September:
Citi’s 2025 Biotech Back to School Conference
Date: W...
Themefolio
Profiler
Peergroup
© PR Newswire
20.08.2025
ISIN: US8342033094
Soleno Therapeutics Inc
SLNO
LISTED
NASDAQ
Soleno Therapeutics (SLNO) Drops Amid Critical Scorpion Report -- Hagens Berman
News Preview
SAN FRANCISCO, Aug. 20, 2025 /PRNewswire/ -- On August 15, 2025, shares in Soleno Therapeutics, Inc. (NASDAQ: SLNO) experienced a significant drop following the release of a highly critical report by Scorpion Capital.
Hagens Berman...
Themefolio
Profiler
Peergroup
© BusinessWire
20.08.2025
ISIN: US01988P1084
Veradigm Inc
MDRX
LISTED
OTC
Veradigm Amends and Extends Stockholder Rights Plan
News Preview
Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, today announced that its Board of Directors (the “Board”) has approved an amendment to extend the Company’s existing Stockholder Rights Plan for an additional six months (the “Rights Plan”).
The Rights Plan, adopted on February 26, 2024, was due to expire...
Themefolio
Profiler
Peergroup
© PR Newswire
20.08.2025
ISIN: US90466Y1038
Unicycive Therapeutics, Inc.
UNCY
LISTED
NASDAQ
UNCY INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Unicycive Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
News Preview
NEW YORK, Aug. 20, 2025 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Unicycive Therapeutics, Inc. ("Unicycive" or "the Company") (NASDAQ: UNCY) and certain of its officers....
Themefolio
Profiler
Peergroup
© BusinessWire
20.08.2025
ISIN: US71742Q1067
Phibro Animal Health Corp
PAHC
LISTED
NASDAQ
Phibro Animal Health Corporation to Host Webcast and Conference Call on Fourth Quarter and Fiscal Year 2025 Results
News Preview
Phibro Animal Health Corporation (Nasdaq: PAHC) expects to announce its fourth quarter and fiscal year 2025 financial results on Wednesday, August 27, 2025, after the market closes. Phibro management will host a conference call and webcast on Thursday, August 28, 2025, at 9:00 AM Eastern Time.
Interested parties are invited to listen to the conf...
Themefolio
Profiler
Peergroup
© BusinessWire
20.08.2025
ISIN: US92532F1003
Vertex Pharmaceuticals Inc
VRTX
LISTED
NASDAQ
Vertex to Participate in Upcoming September Investor Conferences
News Preview
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced management participation in three upcoming investor conferences.
Susie Lisa, Senior Vice President, Investor Relations, and Manisha Pai, Executive Director, Investor Relations, will participate in a fireside chat at the 2025 Wells Fargo Healthcare Conference on Wednesday, Septem...
Themefolio
Profiler
Peergroup
© Globe Newswire
20.08.2025
ISIN: US68062P1066
Olema Pharmaceuticals, Inc.
OLMA
LISTED
NASDAQ
Olema Oncology to Participate in Upcoming Investor Conferences
News Preview
SAN FRANCISCO, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema”, or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for breast cancer and beyond, today announced that the Company will participate in the following up...
Themefolio
Profiler
Peergroup
© Globe Newswire
20.08.2025
ISIN: US09077V1008
BIOAGE Labs Inc
BIOA
LISTED
NASDAQ
BioAge Labs to Present at Upcoming Investor Conferences
News Preview
EMERYVILLE, Calif., Aug. 20, 2025 (GLOBE NEWSWIRE) -- BioAge Labs, Inc. (NASDAQ: BIOA) ("BioAge", "the Company"), a clinical-stage biotechnology company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging, today announced that the Company will participate in the following upcoming investor conf...
Themefolio
Profiler
Peergroup
© Globe Newswire
20.08.2025
ISIN: US4500561067
iRhythm Technologies Inc
IRTC
LISTED
NASDAQ
iRhythm Technologies to Participate in Upcoming Investor Conferences
News Preview
SAN FRANCISCO, Aug. 20, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that its management team is scheduled to present at the following investor conferences....
Themefolio
Profiler
Peergroup
© Globe Newswire
20.08.2025
ISIN: US7995661045
Sana Biotechnology Inc
SANA
LISTED
NASDAQ
Sana Biotechnology Announces Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares
News Preview
SEATTLE, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (Nasdaq: SANA) (“Sana”), a company focused on changing the possible for patients through engineered cells, today announced that it has closed the sale of 3,358,208 shares of its common stock at a price to the public of $3.35 per share, pursuant to the exercise in full of the unde...
Themefolio
Profiler
Peergroup
© Globe Newswire
20.08.2025
ISIN: US00534A1025
Invivyd Inc
IVVD
LISTED
NASDAQ
Invivyd Announces Proposed Public Offering of Common Stock
News Preview
WALTHAM, Mass., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Invivyd) (Nasdaq: IVVD) today announced that it has commenced an underwritten public offering of shares of its common stock. In addition, Invivyd intends to grant the underwriters an option for a period of 30 days to purchase up to an additional 15% of the shares of Invivyd common s...
Themefolio
Profiler
Peergroup
© Globe Newswire
20.08.2025
ISIN: US76243J1051
Rhythm Pharmaceuticals Inc
RYTM
LISTED
NASDAQ
Rhythm Pharmaceuticals Announces FDA Acceptance of sNDA for Setmelanotide in Acquired Hypothalamic Obesity
News Preview
– U.S. Food and Drug Administration accepts sNDA for filing with priority review; sets PDUFA goal date of December 20, 2025 -- – European Medicines Agency accepts and validates submission for Type II variation MAA for setmelanotide to treat acquired hypothalamic obesity –...
Themefolio
Profiler
Peergroup
© Globe Newswire
20.08.2025
ISIN: DK0060257814
Zealand Pharma A/S
ZEAL
LISTED
CPH
Zealand Pharma major shareholder announcement: Van Herk Investments B.V.
News Preview
Company announcement – No. 19 / 2025...
Themefolio
Profiler
Peergroup
© PR Newswire
20.08.2025
ISIN: US4330001060
Hims & Hers Health Inc
HIMS
LISTED
NYSE
Hims & Hers Health Inc. (NYSE: HIMS) Deadline Approaching: Berger Montague Advises Investors of Deadline in Securities Fraud Lawsuit
News Preview
PHILADELPHIA, Aug. 20, 2025 /PRNewswire/ -- Berger Montague, a national securities litigation law firm, is investigating potential securities fraud claims against Hims & Hers Health Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS). The firm is examining whether Hims & Hers, during the Class Period from April 29, 2025 through June 22...
Themefolio
Profiler
Peergroup
© PR Newswire
20.08.2025
ISIN: US88033G4073
Tenet Healthcare Corp
THC
LISTED
NYSE
Tenet and USPI Named Foundational Sponsor of Inaugural AAOS Launchpad Program
News Preview
Strategic partnership aims to empower PGY5 orthopaedic residents with critical tools, mentorship, and resources for a successful transition into practice
ROSEMONT, Ill., Aug. 20, 2025 /PRNewswire/ -- The American Association of Orthopaedic Surgeons (AAOS) announced that Tenet Healthcare (Tenet) and United Surgical Partners International (USPI) ha...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
